Methods and compositions for treating a subject for a lymphatic malformation
Methods of treating lymphatic malformations using a phosphodiesterase type 5 inhibitor are provided. Pharmaceutical compositions and kits comprising phosphodiesterase type 5 inhibitors are also provided.
1. A method of treating a subject for a lymphatic malformation, the method comprising: administering to the subject an amount of sildenafil effective to treat the subject for the lymphatic malformation.
2. The method according to claim 1 , wherein the sildenafil is administered orally.
3. The method according to claim 1 , wherein the subject weighs 10 kg or less, and the amount of sildenafil administered to the subject is 1 mg/kg.
4. The method according to claim 1 , wherein the subject is a human.
5. The method according to claim 1 , further comprising performing compression, surgical resection, laser ablation, or sclerotherapy to the subject.